P3 Health Partners Inc (PIII)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Last updated: Nov 17, 2026 at 4:00 PM ET
P3 Health Partners Inc (PIII) Statistics
P3 Health Partners (PIII) has a market cap of $7.44M and an enterprise value of $85.41M. Its net debt of $77.96M equals 1047.35% of its market cap. Its share count is up 4.01% from a year earlier.
Total Valuation
Enterprise value is 1047.35% above the market cap, as debt exceeds cash.
| Market Cap | $7.44M |
|---|---|
| Enterprise Value | $85.41M |
| Close (Nov 17, 2026) | $2.19 |
Key Dates
The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 67.98% over 52 weeks and trades 58.37% below its 50-day average.
| Beta (1Y) | -0.47 |
|---|---|
| 52-Week Change | -67.98% |
| 1-Month Change | -42.52% |
| 3-Month Change | -78.68% |
| 6-Month Change | -79.12% |
| 5-Year Change | -99.19% |
| Total Return (1Y) | -67.98% |
| Total Return (3Y CAGR) | -66.91% |
| Total Return (5Y CAGR) | -66.24% |
| Return vs SPY (1Y) | -77.34% |
| Max Drawdown (1Y) | -86.70% |
| Max Drawdown (3Y) | -98.25% |
| Sharpe Ratio (1Y) | -0.66 |
| Correlation with SPY (1Y) | -0.04 |
| 50-Day Average | $5.26 |
| 200-Day Average | $6.60 |
| 52-Week Range | $1.52 to $16.89 |
| RSI (14 Days) | 24.8 |
| Average Volume (20 Days) | 58.28K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.53x current liabilities, and total debt is 1.14x shareholder equity.
| Current Ratio | 0.53x |
|---|---|
| Quick Ratio | 0.53x |
| Debt / Equity | 1.14x |
| Debt / EBITDA | 14.77x |
| Interest Coverage | -1.80x |
Returns and Efficiency
Return on invested capital is -32.57% over the last 12 months, against a 5-year average of -20.00%.
| Return on Equity (ROE) | -108.36% |
|---|---|
| Return on Assets (ROA) | -17.36% |
| Return on Invested Capital (ROIC) | -32.57% |
| Return on Capital Employed (ROCE) | -30.99% |
| ROIC (5Y Average) | -20.00% |
| Asset Turnover | 2.30x |
Scores
PIII has an Altman Z-Score of 0.28, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.28 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.55B over the last 12 months is up 10.71% from the 12 months before.
| Revenue | $1.55B |
|---|---|
| Revenue Growth (YoY) | +10.71% |
| Gross Profit | $1.55B |
| Operating Income | -$81.42M |
| Pretax Income | -$127.00M |
| Net Income | -$116.25M |
| EBITDA | $8.25M |
| EBIT | -$81.53M |
| Reported EPS (TTM) | -$23.26 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 16.02% of the $669.72M in total assets.
| Cash and Equivalents | $43.90M |
|---|---|
| Total Debt | $121.86M |
| Net Debt | $77.96M |
| Net Debt Per Share | $22.94 |
| Working Capital | -$190.62M |
| Shareholder Equity | $107.27M |
| Tangible Book Value | -$324.55M |
| Total Assets | $669.72M |
| Total Liabilities | $469.00M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$115.79M |
|---|---|
| FCF Per Share | -$29.65 |
| Depreciation and Amortization | $89.77M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -5.24%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | -5.24% |
| Pretax Margin | -8.17% |
| Net Margin | -7.48% |
| EBITDA Margin | 0.53% |
| EBIT Margin | -5.25% |
Growth
Revenue grew 11.61% a year over 3 years.
| Revenue Growth (3Y CAGR) | +11.61% |
|---|---|
| Revenue Growth (5Y CAGR) | +24.33% |
Dividends and Yields
PIII does not pay a dividend.
| Buyback Yield | -145.36% |
|---|---|
| Shareholder Yield | -145.36% |
Stock Splits
The last split was a 1-for-50 reverse split on Apr 14, 2025.
| Last Split Date | Apr 14, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:50 |
Peer Position
Against 10 similar companies, PIII has the 10th highest ROIC.
ROICPeer median 10.92%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +10.71%
| ROIC | -32.57% vs 10.92% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +10.71% vs +10.71% median |
Analyst Forecast
Consensus estimates put revenue growth at 7.49% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +7.49% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About PIII
What is PIII's market cap?
P3 Health Partners has a market cap of $7.44M. Its enterprise value, which adds debt and subtracts cash, is $85.41M.
How many shares of PIII are outstanding?
P3 Health Partners has 3.40M shares outstanding. The count is up 4.01% from a year earlier.
Does PIII pay a dividend?
No. P3 Health Partners does not pay a dividend.
How much debt does PIII have?
P3 Health Partners has $121.86M of total debt and $43.90M of cash and equivalents, a net debt position of $77.96M.
PIII pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors